MaxCyte, Inc. (MXCT)
NASDAQ · Healthcare
MaxCyte, Inc. Gross Profit 2019–2025
MaxCyte, Inc. annual/quarterly gross profit history and growth rate from 2019 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- MaxCyte, Inc. gross profit for the quarter ending March 31, 2026 was 8.1 M, a 9.12% decrease year-over-year.
- MaxCyte, Inc. gross profit for the twelve months ending March 31, 2026 was 29.2 M, a 9.69% decrease year-over-year.
- MaxCyte, Inc. annual gross profit for 2025 was 26.8 M, a 14.98% decrease from 2024.
- MaxCyte, Inc. annual gross profit for 2024 was 31.5 M, a 13.73% decrease from 2023.
- MaxCyte, Inc. annual gross profit for 2023 was 36.5 M, a 6.68% decrease from 2022.
- MaxCyte, Inc. annual gross profit for 2022 was 39.2 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
MaxCyte, Inc. Gross Profit — FAQ
MaxCyte, Inc. (MXCT) gross profit over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is MaxCyte, Inc.'s gross profit?
MaxCyte, Inc. (MXCT) reported gross profit of $27M for fiscal 2025.
Where can I see MXCT's gross profit history?
The chart and table above show MaxCyte, Inc.'s gross profit by year and by quarter, including the growth rate.